Featured Research

from universities, journals, and other organizations

Bone growth factor may increase benign tumors but not malignant cancer

Date:
September 6, 2013
Source:
Wolters Kluwer Health: Lippincott Williams & Wilkins
Summary:
Patients undergoing spinal fusion surgery with bone morphogenetic protein appear to be at increased risk of benign tumors — but not cancers.

Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors -- but not cancers, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Related Articles


Other papers in the September Neurosurgery report on a stent-assisted approach for difficult-to-treat brain aneurysms and a new software program to help in identifying and protecting critical areas during brain tumor surgery.

BMP Linked to Increased Risk of Benign Tumors

Dr. Nandan Lad of Duke University Medical Center and colleagues analyzed the risk of cancers and benign tumors in nearly 4,700 patients receiving BMP as part of spinal fusion surgery. Bone morphogenetic protein is a growth factor that can promote new bone formation. It is FDA-approved for one specific type of spinal fusion surgery, but has become widely used "off-label" for other fusion procedures.

Contrary to previous smaller studies, patients receiving BMP as commonly used today, had no increase in systemic or malignant cancer risk, compared to a matched group undergoing spinal fusion without BMP. However, spinal fusion with BMP was associated with a higher risk of benign tumors: about 30% higher, after adjustment for other factors.

Although absolute risks were small, patients receiving BMP had a higher rate of benign tumors of the nervous system -- especially of the tissues lining the spinal cord and brain (meninges). The increase in these soft tissue tumors may be related to the "large local dose" of BMP around the spine, the researchers suspect. The results of this large, independent, propensity-matched study suggest that the use of BMP in lumbar fusions is associated with a significantly higher rate of benign neoplasms, but not malignancies.

'Y" Stents Effective for Difficult-to-Treat Brain Aneurysms

Dr. Kyle M. Fargen of University of Florida and colleagues evaluated the use of "Y-stent coiling" to block off (occlude) aneurysms in 45 patients at seven U.S. hospitals. The stent-assisted technique was used for difficult-to-treat aneurysms located at the bifurcation (branching) of two blood vessels.

Y-stent coiling produced "excellent" initial aneurysm occlusion in 84 percent of patients. On angiograms performed at ten months' follow-up, the occlusion rate had increased to 92 percent. Three patients required repeat treatment.

The Y-stent approach provides neurosurgeons with a valuable alternative treatment for aneurysms that would be difficult or impossible to treat with surgery. Based on their findings, Y-stent coiling offers "low complication rates and excellent clinical and angiographic outcomes," Dr. Fargen and coauthors conclude.

New Approach Helps Neurosurgeons Protect 'Eloquent Cortex'

Dr. Vinodh A. Kumar of University of Texas MD Anderson Cancer Center and colleagues evaluated new software that helps locate and protect the "eloquent cortex" -- critical areas involved in speech or movement -- during brain tumor surgery. The program, called "deformable anatomic templates" (DAT), can be overlaid on the patient's brain MRI and displayed in two- and three-dimensions to assess the normal position of eloquent structures relative to the patient's brain tumor. The software is ideally suited for infiltrative brain gliomas.

DAT alerted the surgeon when the glioma was located in or very close to areas of eloquent cortex. In many cases, it provided information that could not be obtained from standard brain-mapping techniques. The study provides "proof of concept that DAT supplements preoperative, intraoperative, and postoperative analysis of eloquent cortex in areas in close proximity to or within gliomas," the researchers write.


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams & Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Shivanand P. Lad, Jacob H. Bagley, Isaac O. Karikari, Ranjith Babu, Beatrice Ugiliweneza, Maiying Kong, Robert E. Isaacs, Carlos A. Bagley, Oren N. Gottfried, Chirag G. Patil, Maxwell Boakye. Cancer After Spinal Fusion. Neurosurgery, 2013; 73 (3): 440 DOI: 10.1227/NEU.0000000000000018

Cite This Page:

Wolters Kluwer Health: Lippincott Williams & Wilkins. "Bone growth factor may increase benign tumors but not malignant cancer." ScienceDaily. ScienceDaily, 6 September 2013. <www.sciencedaily.com/releases/2013/09/130906101040.htm>.
Wolters Kluwer Health: Lippincott Williams & Wilkins. (2013, September 6). Bone growth factor may increase benign tumors but not malignant cancer. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2013/09/130906101040.htm
Wolters Kluwer Health: Lippincott Williams & Wilkins. "Bone growth factor may increase benign tumors but not malignant cancer." ScienceDaily. www.sciencedaily.com/releases/2013/09/130906101040.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins